420 with CNW — New Research Finds Legalization Hasn’t Increased Number of Teens Trying Cannabis

Concerns around how the legalization of marijuana for adult use may prompt an increase in the number of young users have been floated by both parents and health researchers since talks on legalization began a decade ago. Critics against the policy change have even gone as far as to issue warnings with no evidence to back the claims. However, new research has found that the legalization of marijuana does not cause more young individuals to try using the substance.

The study, which was conducted by researchers at Michigan State University, found that legalized marijuana retail sales did not increase the number of underage individuals who consumed cannabis. The researchers cited existing studies on the use of alcohol among the youth to highlight the importance between prevalence and incidence. Research from 2016 and 2018 shows that a big proportion of youth in the United States did not drink alcohol until they could legally. The researchers theorized that the same trend could be true with marijuana.

For their study, the researchers used public data of individuals aged between 12 and 20, then those aged 21 and above, obtained from the National Survey on Drug Use and Health. They analyzed the data using the event study model in an attempt to evaluate the causal effect legalization had on marijuana use. This is in addition to projecting levels of cannabis use if legalization hadn’t been enacted.

They discovered that legalizing adult-use marijuana did increase first-time marijuana consumption — but only among individuals who could use the drug legally once the policy change was enacted. In their report, the researchers noted that they observed no evidence of an increase in use among underage individuals.

The lead author of the study, Barrett Wallace Montgomery, stated that by contrast, the number of individuals aged 21 and above who were trying marijuana for the first time after adult-use legalization could double or triple.

NORML, a marijuana advocacy group, stated in a recent blog post that the study’s findings were consistent with previous research, which had shown that adult-use legalization wasn’t linked to increased access or use among young individuals.

The study was partly funded by the National Institutes of Health and its findings were published in the “PLOS One” journal. The study claims to be the first one designed to assess incidence of use as a result of the legalization of adult-use cannabis. Prior studies have centered on prevalence, trying to measure the effect legalization has had on how much marijuana individuals use or how often they use it.

Marijuana industry actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS) will be pleased to see that independent studies are confirming what they knew all along —rather than increasing underage access, creating legal markets would limit how easy it is for youth to get their hands on marijuana.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Federal Health Agencies Consider Funding Research into Minor Cannabinoids

If you ask the average American if they know what cannabinoids are, they’ll probably mention delta-9 THC, the main psychoactive component in cannabis, or cannabidiol (CBD). These are the most abundant cannabinoids in the cannabis plant as well as the most popular. As a result, they have received a lot of public and scientific attention in the past couple of years amid sweeping cannabis reform.

What many people don’t know is that the cannabis plant produces more than 100 cannabinoids, although most of them occur in small quantities. Cannabis also produces a variety of terpenes and flavonoids that significantly impact the quality of the final product. A group of federal health agencies is now looking into funding research on the possible therapeutic benefits of minor cannabinoids and cannabis terpenes.

The announcement was made via a notice of special interest (NOSI) posted by the National Institutes of Health (NIH) and eight of its component agencies; the NOSI was titled  “Promoting Mechanistic Research on Therapeutic and Other Biological Properties of Minor Cannabinoids and Terpenes.”

Every cannabinoid except THC is considered a minor cannabinoid. While THC has been subject to plenty of research, especially in recent years, there is little scientific research on lesser-known or minor cannabinoids, including CBNCBG and delta-8 THC. The notice states that the agencies are interested in studies involving model organisms and human subjects that look into the impact of terpenes and minor cannabinoids.

The notice goes on to say there is specific interest in preclinical studies of minor cannabinoid-terpene combinations and combinations of minor cannabinoids and other natural products that could enhance health benefits and tamp down on side effects. The notice stated that terpenes and minor cannabinoids may be able to alleviate a wide variety of pathological diseases and conditions; it also encouraged experts from multiple fields to collaborate in this much-needed research.

As per the notice, the eight agencies under the NIH will be tasked with different research objectives and will have specific research requests for scientists. Those agencies include the National Cancer Institute (NCI), the National Center for Complementary and Integrative Health (NCCIH), the National Institute on Aging (NIA), the National Eye Institute (NEI), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), the National Institute of Dental and Craniofacial Research (NIDCR) and  the National Institute of Neurological Disorders and Stroke (NINDS).

NCCIH is interested in the impact of minor cannabinoids and terpenes on pain, NCI is looking to understand how minor cannabinoids and terpenes can affect cancer treatment, and NIAAA plans on researching how CBD and other cannabinoids can impact alcohol use disorder treatment.

This interest in studying the effects of minor cannabis compounds could signal that federal health agencies are beginning to recognize that marijuana does have therapeutic potential, and the time may not be far off when cannabis policy will be overhauled at the federal level so that legitimate companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) can operate nationally if they so choose.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — House Approves Cannabis Research Measure, Senate Expected to Follow Suit

Earlier last week, the House passed a bipartisan cannabis research measure that would make it easier to conduct necessary medical research on this plant. The Senate is expected to pass the measure soon, which will make this bill the first standalone marijuana reform proposal to be advanced to the president’s desk.

The measure, dubbed the Medical Marijuana and Cannabidiol Research Expansion Act, was considered on the U.S. House of Representatives’ floor under the suspension of rules of parliamentary procedure. This procedure is a motion reserved for noncontroversial initiatives that limits debate in the chamber and allows no amendments. For this procedure to be used, no less than two-third support of the House is needed to approve a measure.

The bill, which was sponsored by Rep. Andy Harris and Rep. Earl Blumenauer, was approved by the House in a 325-to-95 vote. Ahead of the vote, some bipartisan legislators spoke favorably about the bill, with the results showing that all Democrats and the majority of the Republicans were in favor of its passage.

On the floor, Harris stated that this measure would make it easier to carry out more studies on cannabis as the American public deserved to know what medical cannabis was useful for. He noted that it would protect patients as well by modernizing the research techniques used and bringing medical cannabis up to the scientific standards set for every other type of drug sold as medication in America.

In a press release, Blumenauer stated that research was a foundational element of marijuana policy, explaining that it was crucial that scientists were able to fully conduct research on the health benefits of marijuana. He also noted that the federal government had stood in the way of progress and science for a long time, which had imposed barriers for scientists who would like to obtain resources and approval to study marijuana. This bicameral bipartisan measure, he declared, would help to change that.

Frank Pallone, chair of the House Energy and Commerce Committee, also stated on the floor that the bill brought Congress to an overdue historic moment, explaining that studies on cannabis had been regulated in a restrictive way because of the plant’s status as a Schedule I substance. This, he explained, meant that the existing research wasn’t an accurate representation of the products available to most individuals in the country.

Meanwhile, Harris and Blumenauer have also advocated for a separate marijuana research initiative, which cleared the chamber a few months ago.

Once the recently passed cannabis research bill gets the nod from the Senate and is signed by the president, studying marijuana could get a little easier for entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS) in their bid to develop products that better serve the diverse needs of the population.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Colorado Firm Set to Conduct Marijuana Research for Alzheimer’s Patients

Over the past decade or so, plenty of studies have found marijuana to be effective at treating the symptoms of a variety of medical conditions. However, most of this research is in its infancy, and experts unanimously agree that we need a lot more clinical trials to definitively prove marijuana’s medical potential.

In Colorado, MedPharma Research, a leading research company in the medical cannabis field, recently announced that it had been granted funding to research the efficacy of marijuana in Alzheimer’s patients. The company submitted a proposal to the Colorado State University Institute of Cannabis Research’s (ICR) FY23 Cannabis Research Opportunity and was ultimately selected for funding.

A panel from the ICR reviewed MedPharma’s proposal and scored it based on approach, significance, environment, broader impact and data analysis. Titled “Isolation and Pharmacological Evaluation of Phytocannabinoids for Alzheimer’s Disease,” the proposal received praise from the ICR panelists due to its novelty, type of training scientific interns received, and the clarity with which it defined evaluation metrics for every data analysis goal.

Given that Alzheimer’s affects millions of Americans and still has no cure, plenty of people stand to benefit if the research from MedPharma uncovers concrete proof of marijuana’s effectiveness. As it stands, there are a variety of treatments that can be used to alleviate Alzheimer’s symptoms and change the progression of the disease. However, there is no cure for the neurodegenerative disease.

The condition is associated with increased levels of inflammation and oxidative stress in the brain. Cannabidiol (CBD), which has anti-inflammatory and anti-oxidant properties, could be used to treat Alzheimer’s by addressing the inflammatory and oxidative mechanisms behind the disease. Scott Karolchyk, MS, RPh, MedPharma director of formulation and development, notes that CBD also has neuroprotective properties, has proven to be effective in vivo in previous studies, and is nonpsychoactive, making it an even more suitable candidate for research into treatments for Alzheimer’s.

He states that the study will give MedPharma the data it needs to develop innovative, bioavailable and bioequivalent dosage forms. MedPharma President Albert Gutierrez said that undertaking such an unprecedented study is what sets his company apart from other companies in the marijuana research and development game. MedPharma will pursue any means it can to develop therapies to treat Alzheimer’s, he said, and studying how compounds such as CBD function will bring the company one step closer to understanding Alzheimer’s.

MedPharma Director of Pharmacology & Experimental Therapeutics Duncan Mackie, PhD, called the announcement a big win for the cannabinoid research community as a whole, stating that it will offer the first clear cellular and mechanistic evidence on the efficacy of cannabis and cannabinoid products against Alzheimer’s.

This and other ongoing marijuana studies are likely to be followed closely by the cannabis industry and its established actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS) since they will add onto the scientific documentation debunking the thinking at the DEA that marijuana has no medical value and should therefore remain a highly controlled substance.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — The Frequency, Implications of Cannabis Use by Millennials

Millions of Americans who grew up during the prohibition era were taught that cannabis is an inherently dangerous drug that encourages drug abuse and criminal activity. To them, cannabis was as dangerous as narcotics such as heroin or cocaine, perhaps even more dangerous because a large focus of the failed war on drugs was on cannabis. The millennial generation, however, generally holds a different view on cannabis compared to older generations.

Nearly 20 states have now passed adult-use cannabis legislation, and in most of these regions, millennials played a significant role in enacting cannabis reform. Sometimes referred to as generation Y, this generation essentially pioneered recreational cannabis reform, at least in the United States, thanks to its ability to be open to new experiences. While older generations can be closed minded, especially regarding controversial issues such as cannabis, millennials are more open minded, putting them at the forefront of social development and change.

A recent survey by market and analytics research firm New Frontier Data sought to understand millennial behaviors and attitudes toward cannabis and their implications. The analytics company found that 39% of the millennials who consume cannabis do so several times a day. Furthermore, the survey revealed that 62% of total cannabis consumption among millennials was recreational, with one of the primary reasons for cannabis use being relaxation.

More than 60% of survey participants said they use both flower and nonflower products while 14% reported using other forms of marijuana exclusively. A majority of the 14% who used other forms of cannabis were women, with 20% of women choosing not to smoke cannabis flower compared to 9% of millennial men.

An estimated 20% of the millennial participants preferred to smoke joints, 14% were more partial to edibles, 9% preferred vapes, and only 6% reported using bongs regularly. Furthermore, 77% of millennials now use cannabis as a substitute for sleep medication, the survey found. The survey also found that 35% of the millennials surveyed used brick-and-mortar stores as their primary source of cannabis, 26% said they get cannabis from friends and family, 20% reported using private dealers and 14% used home-delivery services.

Around 50% said that they usually buy anywhere from $50 to $200 of cannabis with each purchase, and the survey indicated that millennials are more likely to buy more than $200 worth of cannabis per purchase.

Overall, the survey revealed that millennials are more knowledgeable compared to other generations when it comes to cannabis, they are enthusiastic and passionate about cannabis reform, and they are willing to dig deep into their wallets to consume cannabis for both medical and recreational reasons.

Savvy companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) will likely study these survey findings and glean any insights that could help in shaping their future marketing and product development efforts.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — President Biden Reaffirms Pledge to Fulfill Cannabis Campaign Promises

A few months after President Joseph Biden assumed office, his administration passed a major infrastructure bill that, among other things, provided billions of dollars for the development of a nationwide network of public electric vehicle chargers, fulfilling a promise he had made while on the campaign trail. However, the administration has been slow to pass the cannabis reforms President Biden had promised while campaigning, with Biden failing to make a definitive public statement about marijuana policy in the year and a half since he entered the Oval Office.

After more than a year of silence on cannabis reforms, the president has now revealed that his administration is “working on” plans to meet his pledge to pardon and free people who are currently in prison due to cannabis-related offenses. It is the first time he has made a public statement about his administration’s plans to enact cannabis reform since he became the president.

While speaking to journalists on the White House lawn after he stepped off Marine One, Biden said that he didn’t think anyone should be incarcerated for using cannabis. Although he didn’t provide any specifics, the president said that his administration was currently working on a crime bill; press staff from the White House did not respond to further queries for clarification.

Despite dozens of states legalizing cannabis and generating billions of dollars in tax revenue, around 40,000 Americans are currently in prison for marijuana offenses.

According to Richard Bronson, founder and CEO of 70 Million, a staffing agency that serves people with criminal records, people with criminal records “go through hell” to find employment. He said that many of these individuals are men and women of color who, despite serving their time, are still penalized once they enter society. Furthermore, he said the fact that thousands of Americans are still imprisoned for activities that are now legal is an irony of gruesome proportions.

Since he took office, Biden has received several requests from advocates and lawmakers to exercise his executive powers and issue mass pardons for people who were convicted for nonviolent, cannabis-related offenses. His administration has received nearly a dozen letters from advocateslawmakers and others who have been personally impacted by cannabis prohibition to pardon people who are still imprisoned for cannabis offenses,

The only action Biden has taken has been to grant clemency to dozens of people with nonviolent marijuana convictions on their records in April. Although his actions were lauded, they are still a far cry from the mass pardons advocates and lawmakers have been seeking.

To the cannabis industry and its leading actors, such as Cannabis Strategic Ventures Inc. (OTC: NUGS), concrete actions to implement the ending of prohibition or its facets carries more meaning than the current rhetoric to the effect that the matter is being considered.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Revised Lawsuit Wants DOJ to Explain Gun Ban for Medical Marijuana Users

Dozens of states may now allow medical and recreational cannabis, but continued federal prohibition has been a major thorn in the state-legal cannabis industry’s side. Marijuana’s federal classification as a Schedule I drug has made it nigh impossible for cannabis businesses to access financial services and significantly hindered investment in the industry.

Furthermore, federal prohibition has led to plenty of cannabis consumers being penalized for engaging in acts, such as purchasing and consuming cannabis, that are legal in their state. A recent lawsuit seeks to understand the rationale behind one such penalty: preventing medical marijuana users from purchasing guns.

After a recent ruling from the Supreme Court overturned state gun restrictions, a top Florida official filed a lawsuit asking the U.S. Department of Justice to explain why medical marijuana users are barred from buying guns. Citing the Supreme Court ruling, attorneys representing Florida agriculture commissioner Nikki Fried and other plaintiffs recently filed the revised complaint in a federal district court.

They argued that there simply isn’t a historical tradition of stripping people of their second amendment rights to bear arms based on marijuana use. The amendment was ratified more than a century before the United States launched the war on drugs, they say, and doctors were known to prescribe marijuana before America embarked on cannabis prohibition.

Coupled with the SCOTUS ruling, which states that restrictions on gun rights must be consistent with the second amendment, the attorneys argue that the ban preventing medical marijuana users from buying guns simply doesn’t hold water. The filing highlighted marijuana’s history as a “legitimate and legal form of medicine” in Western territories such as America and England, stating that the controversial drug had been discussed and even researched for its drug potential when the second amendment was ratified.

Until the mid-twentieth century, the filing goes on, there were no regulations and laws preventing people who used cannabis from accessing firearms. Commissioner Fried first issued the lawsuit in April, claiming that the Biden administration was acting unconstitutionally by banning guns for medical marijuana users. She directed the lawsuit to the head of the Alcohol, Tobacco, Firearms, and Explosives (ATF) and Attorney General Merrick Garland.

The Department of Justice now has until August 8, 2022, to respond to the revised lawsuit. However, the DOJ has already intimated that rather than defend the rationale behind the gun ban, it plans on filing a motion to dismiss the lawsuit.

It is individual efforts such as the lawsuits filed by Nikki Fried that could help chip away at the vestiges of marijuana prohibition and eventually result in the kind of regulatory environment, which will allow companies such Cannabis Strategic Ventures Inc. (OTC: NUGS) to establish a footprint across the country if they so wish and thrive.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Tips for Cannabis Consumption during the Summer

Summer is all about relaxing and enjoying yourself, whether this is in the form of margaritas by the beach or smoking a joint to improve your mood. However, with multiple heat waves expected this summer, there are a few things you should keep in mind, especially if you plan to consume marijuana.

Cannabis has a “cooling” ability

Some studies suggest that cannabis can lower an individual’s body temperature, with researchers explaining that this may be caused based on how THC interacts with the TRPA-1 receptor. This side effect will come in handy for those living in regions with very high temperatures.

However, this cooling phenomenon doesn’t occur in all weed, with experts noting that the use of consumption methods, which heat the product like dabs or bong rips, may activate the body’s cooling response faster.

Too much heat can weaken your weed

Cannabis needs to be stored properly regardless of where you live, especially if you like to buy it in bulk or don’t smoke frequently.

This is because light breaks down and weakens cannabis while heat causes it to mold. Therefore, during summer months, be sure to store your weed in an airtight glass jar in a cool and dark place to retain its potency.

Keep your edibles from melting

Edibles are perfect for any and all occasions. However, they are almost useless when they melt because they break down in high heat. After purchasing edibles this summer, ensure you store them in a safe place and only take out what you want to consume, leaving the rest in a cool place.

If this will not be possible, then you should consider tinctures and flower because they don’t break down easily in extreme heat.

Be careful as you smoke

If you like vaping, then you should ensure that you store your vape in a cool dark place this summer. Overheating your vape may cause the product to weaken, cause leaks or even cause it to malfunction.

It is also important to remember that glass retains heat, so when using a bong to smoke weed, use use it in a cool place instead of in the summer heat. This will help prevent the glass from cracking or even shattering.

Remember to stay hydrated

It is important to remain hydrated in this summer heat so you don’t pass out. If you aren’t big on smoking but would still like to consume marijuana, then you should consider drinking a cannabis beverage. These drinks will not only refresh you but also get you high much quicker.

When unsure about any aspect of your cannabis experience, it is always advisable to contact the supplier, such as Cannabis Strategic Ventures Inc. (OTC: NUGS), directly for guidance and clarification about your concerns.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — DC Mayor Enacts Measure Allowing Patients to Self-Certify as Medical Cannabis Patients

Dozens of states in the United States have now legalized medical cannabis use. In most of these territories, qualifying patients have to receive a recommendation from their doctor before accessing medical marijuana.

In Washington, DC, however, patients will now be able to certify themselves as medical cannabis patients without a physician’s recommendation after the mayor recently signed emergency legislation into law. The district council approved the measure unanimously last week in a 13 to 0 vote.

The emergency bill effectively allows the council to work around a congressional rider that forbids the district from using federal dollars to launch a recreational cannabis market. Councilmembers Mary Cheh and Kenyan McDuffie first introduced the bill.

Mayor Muriel Bowser said that the legislation would build on efforts by Washington lawmakers to create a patient-centric medical cannabis program. She stated that allowing more patients to access medical marijuana when needed and leveling the playing field for licensed medical marijuana sellers will protect the residents, provide opportunities for local businesses and provide much-needed clarity.

Bowser applauded the district council for approving the legislation, calling it an innovative solution to the complex issues that affect DC’s medical cannabis sector.  Furthermore, she added that she was looking forward to working with the council and the Alcoholic Beverage Regulation Administration (ABRA) on future comprehensive and permanent medical cannabis reform.

Earlier district council chair Phil Mendelson introduced a similar bill that would have facilitated the self-certification process, but DC lawmakers voted it down in April. The bill had received criticism because of provisions that would have given law enforcement leeway to crack down on unlicensed businesses that were taking advantage of current policies to “gift” cannabis to customers who purchased unrelated services and gifts.

Faced with claims that these provisions could further the harms caused by the war on drugs while benefiting existing industry interests, Mendelson said that the bill said nothing about criminal penalties for such establishments.

He argued that such businesses weren’t just a gray market, they are illegal and are eroding the customer bases of licensed medical marijuana businesses. Mendelson said that his measure would make it easier for licensed medical cannabis businesses to maintain their customer base. However, the law failed to advance.

The emergency legislation that was recently signed into law does not contain these enforcement provisions. However, it notes that customers often have little or no barriers to accessing cannabis from “gray” market suppliers.

The growing frustration about the hindrances to the cannabis industry originating from the federal government’s stance isn’t restricted to sector such as Cannabis Strategic Ventures Inc. (OTC: NUGS). Even jurisdictions such as Washington, DC, are reaching the limit of their patience and have started finding workarounds to the outdated federal restrictions as exemplified by the law discussed above.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How Marijuana Retailers Preserve the Quality of Concentrates During Storage

Learning proper storage techniques is crucial for cannabis businesses, especially those looking to succeed in the highly competitive and cutthroat cannabis concentrates segment. Storing cannabis flower isn’t difficult, but improper storage can steadily degrade the cannabis and even lead to the growth of mold. Concentrates, on the other hand, require high-quality storage techniques because they are more sensitive to degradation compared to flower and edibles.

Marijuana concentrates will begin to degrade quickly when exposed to the elements. This means that storing cannabis concentrates products poorly for even a couple of hours could severely degrade them and cause them to change color to black or brown as well as lose their potency and taste. Given the razor-thin profit margins in the concentrates segment, improper storage could have a significant impact on your bottom line.

Duke Barclay, the owner of The Fireplace, a cannabis store in Arcata, California, says that he keeps every concentrate that passes through his hands in a freezer. Once the products are moved onto the sales floor, they are perpetually stored in a small refrigerator. He says that until you plan on either selling or smoking any cannabis concentrate, storing it in a freezer would be best.

In cases where concentrates have lost potency due to improper storage or expiration, Barclay says that retailers are often faced with the choice of either selling the product at a lower cost or reaching out to their supplier for a refund. For instance, multistate cannabis cultivator and concentrate producer 710 Labs was forced to sell products at a 40% discount in the past after a freezer malfunction changed rosin consistency.

According to 710 sales manager Brennan Burke-Martin, retailers who choose not to invest in cold storage may end up sustaining losses down the line due to degraded concentrates. If his company had to sell at a reduced cost even with the necessary cold storage available, companies that don’t buy freezers or refrigerators to store their concentrates are even more likely to sustain losses.

Cold-storing concentrates by type based on how they are extracted is an efficient way to go. Solventless concentrates should be stored at less than -10 degrees in a freezer. 710 Labs recommends storing live rosin, persy rosin and water hash in a freezer under less than -10 degrees. Persy rosin sauce can be stored in a refrigerator or an air-conditioned room that doesn’t exceed 68 degrees.

Burke-Martin recommends that cannabis concentrates made through butane hash oil extraction such as shatter, badder and crumble, should be stored in an air-conditioned room at no more than 68 degrees. However, retailers should ensure they refrigerate or freeze live resin before it is sold.

It is prudent for retailers to know how best to store every kind of marijuana product from different companies such as Cannabis Strategic Ventures, Inc. (OTC: NUGS) because a storage method that is adequate for one product type may be woefully inadequate for another type of product.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.